Description
GPG-NH₂ was shown to inhibit the replication of HIV-1 via its metabolite α-hydroxyglycineamide. The tripeptide added to the antiviral effect of both zidovudine and ritonavir.
GPG-NH₂ was shown to inhibit the replication of HIV-1 via its metabolite α-hydroxyglycineamide. The tripeptide added to the antiviral effect of both zidovudine and ritonavir.
GPG-NH₂ was shown to inhibit the replication of HIV-1 via its metabolite α-hydroxyglycineamide. The tripeptide added to the antiviral effect of both zidovudine and ritonavir.
| Pack size available | 100mg, 1g |
|---|